Kinase inhibitors and cytotoxic drug resistance

被引:19
作者
Grant, S
Dent, P
机构
[1] Virginia Commonwealth Univ, Dept Med, Div Hematol Oncol, Med Coll Virginia, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Radiat Oncol, Med Coll Virginia, Richmond, VA 23298 USA
关键词
D O I
10.1158/1078-0432.CCR-0001-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2205 / 2207
页数:3
相关论文
共 25 条
[1]  
Aszalos A, 1998, ANTICANCER RES, V18, P2937
[2]   BCR-ABL-MEDIATED INHIBITION OF APOPTOSIS WITH DELAY OF G2/M TRANSITION AFTER DNA-DAMAGE - A MECHANISM OF RESISTANCE TO MULTIPLE ANTICANCER AGENTS [J].
BEDI, A ;
BARBER, JP ;
BEDI, GC ;
ELDEIRY, WS ;
SIDRANSKY, D ;
VALA, MS ;
AKHTAR, AJ ;
HILTON, J ;
JONES, RJ .
BLOOD, 1995, 86 (03) :1148-1158
[3]   Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2 [J].
Boudny, V ;
Nakano, S .
BRITISH JOURNAL OF CANCER, 2002, 86 (03) :463-469
[4]   Protein kinase C: A worthwhile target for anticancer drugs? [J].
Caponigro, F ;
French, RC ;
Kaye, SB .
ANTI-CANCER DRUGS, 1997, 8 (01) :26-33
[5]   ZD1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells [J].
Ciardiello, F ;
Caputo, R ;
Borriello, G ;
Del Bufalo, D ;
Biroccio, A ;
Zupi, G ;
Bianco, AR ;
Tortora, G .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (03) :463-469
[6]   Cellular survival: a play in three Akts [J].
Datta, SR ;
Brunet, A ;
Greenberg, ME .
GENES & DEVELOPMENT, 1999, 13 (22) :2905-2927
[7]   INCREASED RESISTANCE TO CYTOTOXIC AGENTS IN ZR75B HUMAN BREAST-CANCER CELLS TRANSFECTED WITH EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
DICKSTEIN, BM ;
WOSIKOWSKI, K ;
BATES, SE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 110 (1-2) :205-211
[8]   BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571 [J].
Donato, NJ ;
Wu, JY ;
Stapley, J ;
Gallick, G ;
Lin, H ;
Arlinghaus, R ;
Talpaz, M .
BLOOD, 2003, 101 (02) :690-698
[9]  
DUXBURY MS, 2004, CLIN CANCER RES, V10, P2203
[10]  
Erlichman C, 2001, CANCER RES, V61, P739